Mediar Therapeutics | RoundOS

Weekly digest by email

Loading companies…

Mediar Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jan 7, 2026	Series B	$76M	Alexandria Real Estate Trust (ARE) — Role not disclosedAmplitude Ventures — Role not disclosedAsahi Kasei Pharma Ventures — Role not disclosedICG — Role not disclosedLongwood Fund — Role not disclosed

Investors

Alexandria Real Estate Trust (ARE)Series B Amplitude VenturesSeries B Asahi Kasei Pharma VenturesSeries B ICGSeries B Longwood FundSeries B

Coverage

Jan 7, 2026Mediar Therapeutics · Series B

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

mediartx.com ↗